SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: muddphudd who wrote (1272)9/9/1998 8:33:00 AM
From: muddphudd  Read Replies (1) | Respond to of 1359
 
Take a look at the September 10 issue of the New England Journal of Medicine (Vol. 339, page 713-732). There are three reports on the incidence of heart valvular defects in association with appetite-suppressant drugs. All show that there is indeed an increase incidence of valve pathology in patients taking these medications, but the incidence is not as high as originally reported.
There are also a couple of editorials/correspondences on the topic.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News